文献速递消化与肝胆胰病理细胞病理与分子病理

世界卫生组织胰胆管细胞病理学报告系统:概要与总结

The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary.
PubMed 文献 · Cancer Cytopathol · 2024-05-06

世界卫生组织(WHO)胰胆管细胞病理学报告系统是对巴氏细胞病理学会报告系统的更新,采用国际统一方法标准化报告胰胆管细胞病理学。该系统对良性肿瘤、导管内肿瘤、黏液性囊性肿瘤和低级别恶性肿瘤的分类进行了重大调整,新增胰腺胆管肿瘤低风险/级别和高风险/级别两个类别,并强调与临床、影像学及辅助检查的相关性。

要点

  • WHO系统将浆液性囊腺瘤归为良性/阴性,胰腺神经内分泌肿瘤等归为恶性。
  • 新增低风险/级别和高风险/级别两类,主要适用于导管内肿瘤和黏液性囊性肿瘤。
  • 每个类别提供样本报告和恶性肿瘤风险及管理建议,便于临床决策。

核心结论

  • WHO系统是胰胆管细胞病理学标准化的国际方法,更新了PSC系统。

研究设计与样本

  • 制定机构为世界卫生组织(WHO),方法为国际专家共识制定标准化报告系统。

主要发现

  • 良性肿瘤如浆液性囊腺瘤从PSC的肿瘤性:良性改为WHO的良性/阴性。
  • 胰腺神经内分泌肿瘤、实性假乳头状肿瘤和胃肠间质瘤从PSC的肿瘤性:其他改为WHO的恶性。
  • 新增胰腺胆管肿瘤低风险/级别和高风险/级别两个类别,主要限于导管内肿瘤和黏液性囊性肿瘤。
  • 低风险/级别病变为黏液性囊肿,伴或不伴低级别上皮异型性;高风险/级别病变含高级别上皮异型性的肿瘤性上皮。

关键数值与推荐

  • WHO系统分类与2019年第5版WHO消化系统肿瘤分类一致。
  • 每个类别提供样本报告和恶性肿瘤风险及管理建议。

临床怎么用

  • 强调细胞病理学与临床、影像学和辅助检查的相关性。
  • 各章节突出关键细胞病理学特征和鉴别诊断,并包括最有用的辅助检查。
  • 提供样本报告和恶性肿瘤风险及管理建议,辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The recently published WHO Reporting System for Pancreaticobiliary Cytopathology (World Health Organization [WHO] System) is an international approach to the standardized reporting of pancreaticobiliary cytopathology, updating the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology (PSC System). Significant changes were made to the categorization of benign neoplasms, intraductal neoplasms, mucinous cystic neoplasms, and malignant neoplasms considered low grade. Benign neoplasms, such as serous cystadenoma, categorized as Neoplastic: benign in the PSC system, are categorized as Benign/negative for malignancy in the WHO system. Pancreatic neuroendocrine tumor, solid-pseudopapillary neoplasm, and gastrointestinal stromal tumor, categorized as Neoplastic: other in the PSC system, are categorized as Malignant in the WHO System in accord with their classification in the 5th edition WHO Classification of Digestive System Tumours (2019). The two new categories of Pancreaticobiliary Neoplasm Low-risk/grade and Pancreaticobiliary Neoplasm High-risk/grade are mostly limited to intraductal neoplasms and mucinous cystic neoplasms. Low-risk/grade lesions are mucinous cysts, with or without low-grade epithelial atypia. High-risk/grade lesions contain neoplastic epithelium with high-grade epithelial atypia. Correlation with clinical, imaging, and ancillary studies remains a key tenet. The sections for each entity are written to highlight key cytopathological features and cytopathological differential diagnoses with the pathologist working in low resource setting in mind. Each section also includes the most pertinent ancillary studies useful for the differential diagnosis. Sample reports are provided for each category. Finally, the book provides a separate section with risk of malignancy and management recommendations for each category to facilitate decision-making for clinicians.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Centeno BA, Saieg M, Siddiqui MT, et al. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 2024. PMID: 38709670. doi:10.1002/cncy.22806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。